Chemical exchange saturation transfer (CEST) imaging is suggested as a new technique for MR-based molecular imaging techniques in vivo and in vitro studies. We hypothesized that newly developed CEST imaging may have a similar potential for differentiating malignant from benign pulmonary nodules and masses, when compared with DWI and FDG-PET/CT. The purpose of this study was to directly and prospectively compare the differentiation capability among CEST imaging, DWI and FDG-PET/CT in patients with pulmonary lesions.
This abstract and the presentation materials are available to members only; a login is required.